Zimran, A.; Szer, J.; Becker-Cohen, M.; Jens, S.; Cozma, C.; Revel-Vilk, S.
The Bone Biomarker of Quantitative Chemical Shift Imaging in Patients with Type 1 Gaucher Disease Receiving Low-Dose Long-Term Enzyme Replacement Therapy. J. Clin. Med. 2023, 12, 2220.
https://doi.org/10.3390/jcm12062220
AMA Style
Zimran A, Szer J, Becker-Cohen M, Jens S, Cozma C, Revel-Vilk S.
The Bone Biomarker of Quantitative Chemical Shift Imaging in Patients with Type 1 Gaucher Disease Receiving Low-Dose Long-Term Enzyme Replacement Therapy. Journal of Clinical Medicine. 2023; 12(6):2220.
https://doi.org/10.3390/jcm12062220
Chicago/Turabian Style
Zimran, Ari, Jeff Szer, Michal Becker-Cohen, Sjoerd Jens, Claudia Cozma, and Shoshana Revel-Vilk.
2023. "The Bone Biomarker of Quantitative Chemical Shift Imaging in Patients with Type 1 Gaucher Disease Receiving Low-Dose Long-Term Enzyme Replacement Therapy" Journal of Clinical Medicine 12, no. 6: 2220.
https://doi.org/10.3390/jcm12062220
APA Style
Zimran, A., Szer, J., Becker-Cohen, M., Jens, S., Cozma, C., & Revel-Vilk, S.
(2023). The Bone Biomarker of Quantitative Chemical Shift Imaging in Patients with Type 1 Gaucher Disease Receiving Low-Dose Long-Term Enzyme Replacement Therapy. Journal of Clinical Medicine, 12(6), 2220.
https://doi.org/10.3390/jcm12062220
